Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Boehringer Ingelheim
Baxter
Dow
Harvard Business School

Last Updated: January 30, 2023

Hydroxyurea - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Drug Prices for hydroxyurea

See drug prices for hydroxyurea

Recent Clinical Trials for hydroxyurea

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NovartisPhase 1/Phase 2
Children's Hospital Los AngelesPhase 1/Phase 2
University of CincinnatiPhase 1

See all hydroxyurea clinical trials

Pharmacology for hydroxyurea
Drug ClassAntimetabolite
Medical Subject Heading (MeSH) Categories for hydroxyurea

US Patents and Regulatory Information for hydroxyurea

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Addmedica Sas SIKLOS hydroxyurea TABLET;ORAL 208843-002 Dec 21, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cheplapharm DROXIA hydroxyurea CAPSULE;ORAL 016295-004 Feb 25, 1998 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cheplapharm DROXIA hydroxyurea CAPSULE;ORAL 016295-002 Feb 25, 1998 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Barr Labs Inc HYDROXYUREA hydroxyurea CAPSULE;ORAL 075020-002 Jun 26, 2000 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Barr Labs Inc HYDROXYUREA hydroxyurea CAPSULE;ORAL 075020-001 Jul 30, 1998 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Boehringer Ingelheim
McKinsey
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.